1-12 of 12
Donata Backhaus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel and Cost-Efficient Measurable Residual Disease (MRD) Detection Assay Using a Single Molecule Molecular Inversion Probe-Based Next Generation Sequencing (NGS) Assay Predicts Overall Survival in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Simon M. Krauß, Tara Holloway, Lara Bischof, Donata Backhaus, Dominic Brauer, Jule Ussmann, Anne Weigert, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch, Klaus H Metzeler
Journal: Blood
Blood (2023) 142 (Supplement 1): 3616.
https://doi.org/10.1182/blood-2023-181728
Published: 2023
Journal Articles

Impact of Typical and Atypical Complex Karyotype Subgroups on Outcome of AML Patients Undergoing Allogeneic Stem Cell Transplantation

Jule Ussmann, Anne Weigert, Lara Bischof, Dominic Brauer, Donata Backhaus, Claudia Diener, Maximilian Merz, Vladan Vucinic, Klaus H Metzeler, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2023) 142 (Supplement 1): 2244.
https://doi.org/10.1182/blood-2023-179713
Published: 2023
Journal Articles

Outcomes of Patients with Acute Myeloid Leukemia Receiving a Second Allogeneic Stem Cell Transplantation

Jule Ussmann, Lara Bischof, Dominic Brauer, Donata Backhaus, Marco Herling, Klaus H. Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2022) 140 (Supplement 1): 4819–4820.
https://doi.org/10.1182/blood-2022-169268
Published: 2022
Journal Articles

Quantitative Impact of Mutated NPM1 MRD in Patients with AML Undergoing Allogeneic Stem Cell Transplantation

Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Elizabeth Gaston, Donata Backhaus, Dominic Brauer, Marco Herling, Maximilian Merz, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Madlen Jentzsch
Journal: Blood
Blood (2022) 140 (Supplement 1): 3412–3413.
https://doi.org/10.1182/blood-2022-163365
Published: 2022
Journal Articles

Prognostic Impact of Measurable Residual Clonal Hematopoiesis after Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Lara Bischof, Elizabeth Gaston, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Lisa Herrmann, Maximilian Merz, Marco Herling, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2022) 140 (Supplement 1): 7750–7751.
https://doi.org/10.1182/blood-2022-169478
Published: 2022
Journal Articles

Outcomes Following Hypomethylating Agent / Venetoclax Combination-Therapy for MDS or AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Lara Bischof, Jule Ussmann, Donata Backhaus, Georg-Nikolaus Franke, Vladan Vucinic, Marco Herling, Maximilian Merz, Leanthe Braunert, Doreen Hammerschmidt, Alexander Kühnemund, Anne Weigert, Klaus H. Metzeler, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 4808–4809.
https://doi.org/10.1182/blood-2022-163363
Published: 2022
Journal Articles

Prognostic Impact of the 2022 European Leukemia Net Risk Classification in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H. Metzeler, Marco Herling, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Uwe Platzbecker, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 10601–10602.
https://doi.org/10.1182/blood-2022-164842
Published: 2022
Journal Articles

Diagnostic Red Blood Cell Distribution Width As a Prognostic Factor in Acute Myeloid Leukemia

Vladan Vucinic, Leo Ruhnke, Katja Sockel, Maximilian Alexander Röhnert, Donata Backhaus, Dominic Brauer, Georg-Nikolaus Franke, Dietger Niederwieser, Martin Bornhäuser, Christoph Rollig, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2021) 138 (Supplement 1): 1227.
https://doi.org/10.1182/blood-2021-145497
Published: 2021
Journal Articles

Applicability of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) to Predict Outcomes of Acute Myeloid Leukemia Patients Older Than 60 Years Undergoing Non-Myeloablative Allogeneic Stem Cell Transplantation

Donata Backhaus, Madlen Jentzsch, Dominic Brauer, Julia Schulz, Vladan Vucinic, Georg-Nikolaus Franke, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Journal: Blood
Blood (2021) 138 (Supplement 1): 1797.
https://doi.org/10.1182/blood-2021-150712
Published: 2021
Journal Articles

Differential Prognostic Relevance of Measurable Residual Disease in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in First Versus Second Morphologic Remission

Madlen Jentzsch, Johannes Küpper, Dominic Brauer, Donata Backhaus, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Journal: Blood
Blood (2021) 138 (Supplement 1): 416.
https://doi.org/10.1182/blood-2021-144794
Published: 2021
Journal Articles

Prognostic Impact of Nutritional Status at Diagnosis and Weight Changes in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Donata Backhaus, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD PhD, Uwe Platzbecker, Madlen Jentzsch, MD, Sebastian Schwind, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134187
Published: 2020
Journal Articles

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

Madlen Jentzsch, MD, Dominic Brauer, Juliane Grimm, MD, Marius Bill, MD PhD, Donata Backhaus, MD, Julia Schulz, Dietger Niederweiser, MD, Uwe Platzbecker, Sebastian Schwind, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-134102
Published: 2020